Harmony Biosciences Holdings (HRMY) Intangibles (2019 - 2026)
Harmony Biosciences Holdings (HRMY) posted Intangibles of $83.5 million for Q1 2026, down 6.67% sequentially from $89.4 million in Q4 2025, and down 61.18% YoY from $215.0 million in Q1 2025.
Harmony Biosciences Holdings (HRMY) Intangibles (2019 - 2026) Analysis & Trends
Harmony Biosciences Holdings has reported Intangibles for 8 years, with the latest figure at $83.5 million in Q1 2026.
- Quarterly Intangibles fell 61.18% year-over-year to $83.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $83.5 million (down 61.18% YoY) and the FY2025 annual result came in at $89.4 million, down 21.05% from the prior year.
- Intangibles fell to $83.5 million in Q1 2026 per HRMY's latest filing, from $89.4 million in the prior quarter.
- Over five years, Intangibles peaked at $215.0 million in Q3 2022 and troughed at $83.5 million in Q1 2026.
- A 5-year average of $175.9 million and a median of $215.0 million in 2022 frame the typical range for Intangibles.
- The sharpest annual moves came in 2025 and 2026: Intangibles surged 63.94% in 2025, then slumped 61.18% in 2026.
- Over 5 years, Intangibles stood at $215.0 million in 2022, then tumbled by 36.23% to $137.1 million in 2023, then slipped by 17.39% to $113.3 million in 2024, then declined by 21.05% to $89.4 million in 2025, then fell by 6.67% to $83.5 million in 2026.
- According to Business Quant data, Intangibles over the past three periods registered $83.5 million, $89.4 million, and $215.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 412.80 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 1.31 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 266.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 63.28 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 60.96 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 93.49 Mn |
| 10 | Harmony Biosciences Holdings | 2.22 Bn | 1.41 Bn | 198.08 Mn | 215.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 215.00 Mn |
| Mar 31, 2026 | 83.46 Mn |
| Dec 31, 2025 | 89.42 Mn |
| Sep 30, 2025 | 215.00 Mn |
| Jun 30, 2025 | 215.00 Mn |
| Mar 31, 2025 | 215.00 Mn |
| Dec 31, 2024 | 113.26 Mn |
| Sep 30, 2024 | 215.00 Mn |
| Jun 30, 2024 | 215.00 Mn |
| Mar 31, 2024 | 131.15 Mn |
| Dec 31, 2023 | 137.11 Mn |
| Sep 30, 2023 | 215.00 Mn |
| Jun 30, 2023 | 149.03 Mn |
| Mar 31, 2023 | 215.00 Mn |
| Dec 31, 2022 | 215.00 Mn |
| Sep 30, 2022 | 215.00 Mn |
| Jun 30, 2022 | 172.88 Mn |
| Mar 31, 2022 | 178.84 Mn |
| Dec 31, 2021 | 143.92 Mn |
| Sep 30, 2021 | 175.00 Mn |